MedPlast offers a broad range of engineering and manufacturing capabilities that support the world’s leading original equipment manufacturers with producing diagnostic, orthopedic, surgical and other medical products. The company employs more than 1,800 engineers, technicians and assembly workers who specialize in technical molding, advanced processing, device assembly and implantables. MedPlast is well-respected and trusted for its high regulatory and quality standards that meet the healthcare industry’s stringent regulations. Water Street intends to build on MedPlast’s global network and capabilities through targeted acquisitions and organic initiatives to form an integrated portfolio of end-to-end product solutions.
President & CEOWork with us
Brian King brings more than 25 years of executive operating experience to MedPlast. Previously, he served as chief transformation officer for the DePuy Synthes Companies of Johnson & Johnson, where he was responsible for improving the performance of the combined $10B businesses and served as a member of the Orthopedics Group Operating Committee. Brian also spent ten years at Covidien, where he held positions of increasing responsibility. He was group president of the $2B emerging markets division (Asia, EMEA, South America). He also served as president of Asia and senior vice president of corporate operations. Earlier in his career, Brian held executive positions with enterprises in the oncology pharmaceutical and energy commodities sectors. He also worked as a consultant at McKinsey & Co., general manager for the Aluminum Company of America (Alcoa) and held leadership positions at Allegheny Teledyne. Brian serves on the boards of directors of Novanta Inc. and PCI Pharma Services. He is a graduate of the U.S. Naval Academy and served as a jet pilot in the U.S. Navy. He holds a master’s degree in civil engineering from the Pennsylvania State University and a master’s in business administration from Harvard Business School.